Neuralink, Elon Musk's brain-computer interface company, is under increased scrutiny following its first human implant. The procedure, performed in January 2024, aimed to allow a paralyzed patient to control a computer cursor using their thoughts.
While initial reports indicated positive results, including the ability to move the cursor, concerns have emerged regarding the long-term effects and safety of the device. The Food and Drug Administration (FDA) is closely monitoring the situation, and independent experts are calling for more transparency.
The company has stated that the patient is recovering well and that they are continuously working to improve the technology. However, the long-term implications of the implant, including potential risks of infection or device malfunction, remain a subject of debate within the scientific community.